Summary
A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.
In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.
According to APO Research, The global Medical Isotopes market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Medical Isotopes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Medical Isotopes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Medical Isotopes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Medical Isotopes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Medical Isotopes include NRG, NTP Radioisotopes, JSC Isotope, ANSTO, IRE, Nordion, Curium Pharma, Cambridge Isotope Laboratories and Eckert & Ziegler Strahlen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Medical Isotopes, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Medical Isotopes, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Isotopes, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Medical Isotopes revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Medical Isotopes market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Medical Isotopes revenue, projected growth trends, production technology, application and end-user industry.
Medical Isotopes segment by Company
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
IRE
Nordion
Curium Pharma
Cambridge Isotope Laboratories
Eckert & Ziegler Strahlen
Polatom
Center of Molecular Research
China National Nuclear Corporation
Urenco
LANL
Shanghai Engineering Research Center
IDB Holland
NHTC
Linde
ORNL
SI Science
Medical Isotopes segment by Type
Stable Isotopes
Radioisotopes
Medical Isotopes segment by Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Medical Isotopes segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Isotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Isotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Isotopes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Medical Isotopes in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Medical Isotopes company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Isotopes revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Medical Isotopes Market by Type
1.2.1 Global Medical Isotopes Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Stable Isotopes
1.2.3 Radioisotopes
1.3 Medical Isotopes Market by Application
1.3.1 Global Medical Isotopes Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Nuclear Therapy
1.3.3 Equipment Radioactive Source
1.3.4 Diagnosis
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Medical Isotopes Market Dynamics
2.1 Medical Isotopes Industry Trends
2.2 Medical Isotopes Industry Drivers
2.3 Medical Isotopes Industry Opportunities and Challenges
2.4 Medical Isotopes Industry Restraints
3 Global Growth Perspective
3.1 Global Medical Isotopes Market Perspective (2019-2030)
3.2 Global Medical Isotopes Growth Trends by Region
3.2.1 Global Medical Isotopes Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Medical Isotopes Market Size by Region (2019-2024)
3.2.3 Global Medical Isotopes Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Medical Isotopes Revenue by Players
4.1.1 Global Medical Isotopes Revenue by Players (2019-2024)
4.1.2 Global Medical Isotopes Revenue Market Share by Players (2019-2024)
4.1.3 Global Medical Isotopes Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Medical Isotopes Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Medical Isotopes Key Players Headquarters & Area Served
4.4 Global Medical Isotopes Players, Product Type & Application
4.5 Global Medical Isotopes Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Medical Isotopes Market CR5 and HHI
4.6.2 Global Top 5 and 10 Medical Isotopes Players Market Share by Revenue in 2023
4.6.3 2023 Medical Isotopes Tier 1, Tier 2, and Tier 3
5 Medical Isotopes Market Size by Type
5.1 Global Medical Isotopes Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Medical Isotopes Revenue by Type (2019-2030)
5.3 Global Medical Isotopes Revenue Market Share by Type (2019-2030)
6 Medical Isotopes Market Size by Application
6.1 Global Medical Isotopes Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Medical Isotopes Revenue by Application (2019-2030)
6.3 Global Medical Isotopes Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 NRG
7.1.1 NRG Comapny Information
7.1.2 NRG Business Overview
7.1.3 NRG Medical Isotopes Revenue and Gross Margin (2019-2024)
7.1.4 NRG Medical Isotopes Product Portfolio
7.1.5 NRG Recent Developments
7.2 NTP Radioisotopes
7.2.1 NTP Radioisotopes Comapny Information
7.2.2 NTP Radioisotopes Business Overview
7.2.3 NTP Radioisotopes Medical Isotopes Revenue and Gross Margin (2019-2024)
7.2.4 NTP Radioisotopes Medical Isotopes Product Portfolio
7.2.5 NTP Radioisotopes Recent Developments
7.3 JSC Isotope
7.3.1 JSC Isotope Comapny Information
7.3.2 JSC Isotope Business Overview
7.3.3 JSC Isotope Medical Isotopes Revenue and Gross Margin (2019-2024)
7.3.4 JSC Isotope Medical Isotopes Product Portfolio
7.3.5 JSC Isotope Recent Developments
7.4 ANSTO
7.4.1 ANSTO Comapny Information
7.4.2 ANSTO Business Overview
7.4.3 ANSTO Medical Isotopes Revenue and Gross Margin (2019-2024)
7.4.4 ANSTO Medical Isotopes Product Portfolio
7.4.5 ANSTO Recent Developments
7.5 IRE
7.5.1 IRE Comapny Information
7.5.2 IRE Business Overview
7.5.3 IRE Medical Isotopes Revenue and Gross Margin (2019-2024)
7.5.4 IRE Medical Isotopes Product Portfolio
7.5.5 IRE Recent Developments
7.6 Nordion
7.6.1 Nordion Comapny Information
7.6.2 Nordion Business Overview
7.6.3 Nordion Medical Isotopes Revenue and Gross Margin (2019-2024)
7.6.4 Nordion Medical Isotopes Product Portfolio
7.6.5 Nordion Recent Developments
7.7 Curium Pharma
7.7.1 Curium Pharma Comapny Information
7.7.2 Curium Pharma Business Overview
7.7.3 Curium Pharma Medical Isotopes Revenue and Gross Margin (2019-2024)
7.7.4 Curium Pharma Medical Isotopes Product Portfolio
7.7.5 Curium Pharma Recent Developments
7.8 Cambridge Isotope Laboratories
7.8.1 Cambridge Isotope Laboratories Comapny Information
7.8.2 Cambridge Isotope Laboratories Business Overview
7.8.3 Cambridge Isotope Laboratories Medical Isotopes Revenue and Gross Margin (2019-2024)
7.8.4 Cambridge Isotope Laboratories Medical Isotopes Product Portfolio
7.8.5 Cambridge Isotope Laboratories Recent Developments
7.9 Eckert & Ziegler Strahlen
7.9.1 Eckert & Ziegler Strahlen Comapny Information
7.9.2 Eckert & Ziegler Strahlen Business Overview
7.9.3 Eckert & Ziegler Strahlen Medical Isotopes Revenue and Gross Margin (2019-2024)
7.9.4 Eckert & Ziegler Strahlen Medical Isotopes Product Portfolio
7.9.5 Eckert & Ziegler Strahlen Recent Developments
7.10 Polatom
7.10.1 Polatom Comapny Information
7.10.2 Polatom Business Overview
7.10.3 Polatom Medical Isotopes Revenue and Gross Margin (2019-2024)
7.10.4 Polatom Medical Isotopes Product Portfolio
7.10.5 Polatom Recent Developments
7.11 Center of Molecular Research
7.11.1 Center of Molecular Research Comapny Information
7.11.2 Center of Molecular Research Business Overview
7.11.3 Center of Molecular Research Medical Isotopes Revenue and Gross Margin (2019-2024)
7.11.4 Center of Molecular Research Medical Isotopes Product Portfolio
7.11.5 Center of Molecular Research Recent Developments
7.12 China National Nuclear Corporation
7.12.1 China National Nuclear Corporation Comapny Information
7.12.2 China National Nuclear Corporation Business Overview
7.12.3 China National Nuclear Corporation Medical Isotopes Revenue and Gross Margin (2019-2024)
7.12.4 China National Nuclear Corporation Medical Isotopes Product Portfolio
7.12.5 China National Nuclear Corporation Recent Developments
7.13 Urenco
7.13.1 Urenco Comapny Information
7.13.2 Urenco Business Overview
7.13.3 Urenco Medical Isotopes Revenue and Gross Margin (2019-2024)
7.13.4 Urenco Medical Isotopes Product Portfolio
7.13.5 Urenco Recent Developments
7.14 LANL
7.14.1 LANL Comapny Information
7.14.2 LANL Business Overview
7.14.3 LANL Medical Isotopes Revenue and Gross Margin (2019-2024)
7.14.4 LANL Medical Isotopes Product Portfolio
7.14.5 LANL Recent Developments
7.15 Shanghai Engineering Research Center
7.15.1 Shanghai Engineering Research Center Comapny Information
7.15.2 Shanghai Engineering Research Center Business Overview
7.15.3 Shanghai Engineering Research Center Medical Isotopes Revenue and Gross Margin (2019-2024)
7.15.4 Shanghai Engineering Research Center Medical Isotopes Product Portfolio
7.15.5 Shanghai Engineering Research Center Recent Developments
7.16 IDB Holland
7.16.1 IDB Holland Comapny Information
7.16.2 IDB Holland Business Overview
7.16.3 IDB Holland Medical Isotopes Revenue and Gross Margin (2019-2024)
7.16.4 IDB Holland Medical Isotopes Product Portfolio
7.16.5 IDB Holland Recent Developments
7.17 NHTC
7.17.1 NHTC Comapny Information
7.17.2 NHTC Business Overview
7.17.3 NHTC Medical Isotopes Revenue and Gross Margin (2019-2024)
7.17.4 NHTC Medical Isotopes Product Portfolio
7.17.5 NHTC Recent Developments
7.18 Linde
7.18.1 Linde Comapny Information
7.18.2 Linde Business Overview
7.18.3 Linde Medical Isotopes Revenue and Gross Margin (2019-2024)
7.18.4 Linde Medical Isotopes Product Portfolio
7.18.5 Linde Recent Developments
7.19 ORNL
7.19.1 ORNL Comapny Information
7.19.2 ORNL Business Overview
7.19.3 ORNL Medical Isotopes Revenue and Gross Margin (2019-2024)
7.19.4 ORNL Medical Isotopes Product Portfolio
7.19.5 ORNL Recent Developments
7.20 SI Science
7.20.1 SI Science Comapny Information
7.20.2 SI Science Business Overview
7.20.3 SI Science Medical Isotopes Revenue and Gross Margin (2019-2024)
7.20.4 SI Science Medical Isotopes Product Portfolio
7.20.5 SI Science Recent Developments
8 North America
8.1 North America Medical Isotopes Revenue (2019-2030)
8.2 North America Medical Isotopes Revenue by Type (2019-2030)
8.2.1 North America Medical Isotopes Revenue by Type (2019-2024)
8.2.2 North America Medical Isotopes Revenue by Type (2025-2030)
8.3 North America Medical Isotopes Revenue Share by Type (2019-2030)
8.4 North America Medical Isotopes Revenue by Application (2019-2030)
8.4.1 North America Medical Isotopes Revenue by Application (2019-2024)
8.4.2 North America Medical Isotopes Revenue by Application (2025-2030)
8.5 North America Medical Isotopes Revenue Share by Application (2019-2030)
8.6 North America Medical Isotopes Revenue by Country
8.6.1 North America Medical Isotopes Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Medical Isotopes Revenue by Country (2019-2024)
8.6.3 North America Medical Isotopes Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Medical Isotopes Revenue (2019-2030)
9.2 Europe Medical Isotopes Revenue by Type (2019-2030)
9.2.1 Europe Medical Isotopes Revenue by Type (2019-2024)
9.2.2 Europe Medical Isotopes Revenue by Type (2025-2030)
9.3 Europe Medical Isotopes Revenue Share by Type (2019-2030)
9.4 Europe Medical Isotopes Revenue by Application (2019-2030)
9.4.1 Europe Medical Isotopes Revenue by Application (2019-2024)
9.4.2 Europe Medical Isotopes Revenue by Application (2025-2030)
9.5 Europe Medical Isotopes Revenue Share by Application (2019-2030)
9.6 Europe Medical Isotopes Revenue by Country
9.6.1 Europe Medical Isotopes Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Medical Isotopes Revenue by Country (2019-2024)
9.6.3 Europe Medical Isotopes Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Medical Isotopes Revenue (2019-2030)
10.2 China Medical Isotopes Revenue by Type (2019-2030)
10.2.1 China Medical Isotopes Revenue by Type (2019-2024)
10.2.2 China Medical Isotopes Revenue by Type (2025-2030)
10.3 China Medical Isotopes Revenue Share by Type (2019-2030)
10.4 China Medical Isotopes Revenue by Application (2019-2030)
10.4.1 China Medical Isotopes Revenue by Application (2019-2024)
10.4.2 China Medical Isotopes Revenue by Application (2025-2030)
10.5 China Medical Isotopes Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Medical Isotopes Revenue (2019-2030)
11.2 Asia Medical Isotopes Revenue by Type (2019-2030)
11.2.1 Asia Medical Isotopes Revenue by Type (2019-2024)
11.2.2 Asia Medical Isotopes Revenue by Type (2025-2030)
11.3 Asia Medical Isotopes Revenue Share by Type (2019-2030)
11.4 Asia Medical Isotopes Revenue by Application (2019-2030)
11.4.1 Asia Medical Isotopes Revenue by Application (2019-2024)
11.4.2 Asia Medical Isotopes Revenue by Application (2025-2030)
11.5 Asia Medical Isotopes Revenue Share by Application (2019-2030)
11.6 Asia Medical Isotopes Revenue by Country
11.6.1 Asia Medical Isotopes Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Medical Isotopes Revenue by Country (2019-2024)
11.6.3 Asia Medical Isotopes Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Medical Isotopes Revenue (2019-2030)
12.2 MEALA Medical Isotopes Revenue by Type (2019-2030)
12.2.1 MEALA Medical Isotopes Revenue by Type (2019-2024)
12.2.2 MEALA Medical Isotopes Revenue by Type (2025-2030)
12.3 MEALA Medical Isotopes Revenue Share by Type (2019-2030)
12.4 MEALA Medical Isotopes Revenue by Application (2019-2030)
12.4.1 MEALA Medical Isotopes Revenue by Application (2019-2024)
12.4.2 MEALA Medical Isotopes Revenue by Application (2025-2030)
12.5 MEALA Medical Isotopes Revenue Share by Application (2019-2030)
12.6 MEALA Medical Isotopes Revenue by Country
12.6.1 MEALA Medical Isotopes Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Medical Isotopes Revenue by Country (2019-2024)
12.6.3 MEALA Medical Isotopes Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Medical Isotopes Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Stable Isotopes Major Manufacturers
Table 2. Radioisotopes Major Manufacturers
Table 3. Global Medical Isotopes Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 4. Nuclear Therapy Major Manufacturers
Table 5. Equipment Radioactive Source Major Manufacturers
Table 6. Diagnosis Major Manufacturers
Table 7. Medical Isotopes Industry Trends
Table 8. Medical Isotopes Industry Drivers
Table 9. Medical Isotopes Industry Opportunities and Challenges
Table 10. Medical Isotopes Industry Restraints
Table 11. Global Medical Isotopes Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Medical Isotopes Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Medical Isotopes Market Share by Region (2019-2024)
Table 14. Global Medical Isotopes Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Medical Isotopes Market Share by Region (2025-2030)
Table 16. Global Medical Isotopes Revenue by Players (US$ Million) & (2019-2024)
Table 17. Global Medical Isotopes Revenue Market Share by Players (2019-2024)
Table 18. Global Medical Isotopes Key Players Ranking, 2022 VS 2023 VS 2024
Table 19. Global Medical Isotopes Key Players Headquarters & Area Served
Table 20. Global Medical Isotopes Players, Product Type & Application
Table 21. Global Medical Isotopes Players Commercialization Time
Table 22. Global Players Market Concentration Ratio (CR5 and HHI)
Table 23. Global Medical Isotopes by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 24. Global Medical Isotopes Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Medical Isotopes Revenue by Type (2019-2024) & (US$ Million)
Table 26. Global Medical Isotopes Revenue by Type (2025-2030) & (US$ Million)
Table 27. Global Medical Isotopes Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 28. Global Medical Isotopes Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 29. Global Medical Isotopes Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Medical Isotopes Revenue by Application (2019-2024) & (US$ Million)
Table 31. Global Medical Isotopes Revenue by Application (2025-2030) & (US$ Million)
Table 32. Global Medical Isotopes Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 33. Global Medical Isotopes Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 34. NRG Company Information
Table 35. NRG Business Overview
Table 36. NRG Medical Isotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 37. NRG Medical Isotopes Product Portfolio
Table 38. NRG Recent Development
Table 39. NTP Radioisotopes Company Information
Table 40. NTP Radioisotopes Business Overview
Table 41. NTP Radioisotopes Medical Isotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 42. NTP Radioisotopes Medical Isotopes Product Portfolio
Table 43. NTP Radioisotopes Recent Development
Table 44. JSC Isotope Company Information
Table 45. JSC Isotope Business Overview
Table 46. JSC Isotope Medical Isotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 47. JSC Isotope Medical Isotopes Product Portfolio
Table 48. JSC Isotope Recent Development
Table 49. ANSTO Company Information
Table 50. ANSTO Business Overview
Table 51. ANSTO Medical Isotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 52. ANSTO Medical Isotopes Product Portfolio
Table 53. ANSTO Recent Development
Table 54. IRE Company Information
Table 55. IRE Business Overview
Table 56. IRE Medical Isotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 57. IRE Medical Isotopes Product Portfolio
Table 58. IRE Recent Development
Table 59. Nordion Company Information
Table 60. Nordion Business Overview
Table 61. Nordion Medical Isotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 62. Nordion Medical Isotopes Product Portfolio
Table 63. Nordion Recent Development
Table 64. Curium Pharma Company Information
Table 65. Curium Pharma Business Overview
Table 66. Curium Pharma Medical Isotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 67. Curium Pharma Medical Isotopes Product Portfolio
Table 68. Curium Pharma Recent Development
Table 69. Cambridge Isotope Laboratories Company Information
Table 70. Cambridge Isotope Laboratories Business Overview
Table 71. Cambridge Isotope Laboratories Medical Isotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 72. Cambridge Isotope Laboratories Medical Isotopes Product Portfolio
Table 73. Cambridge Isotope Laboratories Recent Development
Table 74. Eckert & Ziegler Strahlen Company Information
Table 75. Eckert & Ziegler Strahlen Business Overview
Table 76. Eckert & Ziegler Strahlen Medical Isotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 77. Eckert & Ziegler Strahlen Medical Isotopes Product Portfolio
Table 78. Eckert & Ziegler Strahlen Recent Development
Table 79. Polatom Company Information
Table 80. Polatom Business Overview
Table 81. Polatom Medical Isotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 82. Polatom Medical Isotopes Product Portfolio
Table 83. Polatom Recent Development
Table 84. Center of Molecular Research Company Information
Table 85. Center of Molecular Research Business Overview
Table 86. Center of Molecular Research Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Center of Molecular Research Medical Isotopes Product Portfolio
Table 88. Center of Molecular Research Recent Development
Table 89. China National Nuclear Corporation Company Information
Table 90. China National Nuclear Corporation Business Overview
Table 91. China National Nuclear Corporation Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. China National Nuclear Corporation Medical Isotopes Product Portfolio
Table 93. China National Nuclear Corporation Recent Development
Table 94. Urenco Company Information
Table 95. Urenco Business Overview
Table 96. Urenco Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Urenco Medical Isotopes Product Portfolio
Table 98. Urenco Recent Development
Table 99. LANL Company Information
Table 100. LANL Business Overview
Table 101. LANL Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. LANL Medical Isotopes Product Portfolio
Table 103. LANL Recent Development
Table 104. Shanghai Engineering Research Center Company Information
Table 105. Shanghai Engineering Research Center Business Overview
Table 106. Shanghai Engineering Research Center Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. Shanghai Engineering Research Center Medical Isotopes Product Portfolio
Table 108. Shanghai Engineering Research Center Recent Development
Table 109. IDB Holland Company Information
Table 110. IDB Holland Business Overview
Table 111. IDB Holland Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. IDB Holland Medical Isotopes Product Portfolio
Table 113. IDB Holland Recent Development
Table 114. NHTC Company Information
Table 115. NHTC Business Overview
Table 116. NHTC Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. NHTC Medical Isotopes Product Portfolio
Table 118. NHTC Recent Development
Table 119. Linde Company Information
Table 120. Linde Business Overview
Table 121. Linde Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Linde Medical Isotopes Product Portfolio
Table 123. Linde Recent Development
Table 124. ORNL Company Information
Table 125. ORNL Business Overview
Table 126. ORNL Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. ORNL Medical Isotopes Product Portfolio
Table 128. ORNL Recent Development
Table 129. SI Science Company Information
Table 130. SI Science Business Overview
Table 131. SI Science Medical Isotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. SI Science Medical Isotopes Product Portfolio
Table 133. SI Science Recent Development
Table 134. North America Medical Isotopes Revenue by Type (2019-2024) & (US$ Million)
Table 135. North America Medical Isotopes Revenue by Application (2019-2024) & (US$ Million)
Table 136. North America Medical Isotopes Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 137. North America Medical Isotopes Revenue by Country (2019-2024) & (US$ Million)
Table 138. North America Medical Isotopes Revenue by Country (2025-2030) & (US$ Million)
Table 139. Europe Medical Isotopes Revenue by Type (2019-2024) & (US$ Million)
Table 140. Europe Medical Isotopes Revenue by Application (2019-2024) & (US$ Million)
Table 141. Europe Medical Isotopes Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 142. Europe Medical Isotopes Revenue by Country (2019-2024) & (US$ Million)
Table 143. Europe Medical Isotopes Revenue by Country (2025-2030) & (US$ Million)
Table 144. China Medical Isotopes Revenue by Type (2019-2024) & (US$ Million)
Table 145. China Medical Isotopes Revenue by Application (2019-2024) & (US$ Million)
Table 146. Asia Medical Isotopes Revenue by Type (2019-2024) & (US$ Million)
Table 147. Asia Medical Isotopes Revenue by Application (2019-2024) & (US$ Million)
Table 148. Asia Medical Isotopes Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 149. Asia Medical Isotopes Revenue by Country (2019-2024) & (US$ Million)
Table 150. Asia Medical Isotopes Revenue by Country (2025-2030) & (US$ Million)
Table 151. MEALA Medical Isotopes Revenue by Type (2019-2024) & (US$ Million)
Table 152. MEALA Medical Isotopes Revenue by Application (2019-2024) & (US$ Million)
Table 153. MEALA Medical Isotopes Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 154. MEALA Medical Isotopes Revenue by Country (2019-2024) & (US$ Million)
Table 155. MEALA Medical Isotopes Revenue by Country (2025-2030) & (US$ Million)
Table 156. Research Programs/Design for This Report
Table 157. Authors List of This Report
Table 158. Secondary Sources
Table 159. Primary Sources
List of Figures
Figure 1. Medical Isotopes Product Picture
Figure 2. Global Medical Isotopes Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Medical Isotopes Market Size Share 2019 VS 2023 VS 2030
Figure 4. Stable Isotopes Picture
Figure 5. Radioisotopes Picture
Figure 6. Global Medical Isotopes Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Medical Isotopes Market Size Share 2019 VS 2023 VS 2030
Figure 8. Nuclear Therapy Picture
Figure 9. Equipment Radioactive Source Picture
Figure 10. Diagnosis Picture
Figure 11. Global Medical Isotopes Market Size (US$ Million) & (2019-2030)
Figure 12. Global Medical Isotopes Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Medical Isotopes Market Share by Region: 2019 VS 2023 VS 2030
Figure 14. Global Medical Isotopes Players Revenue Share Top 10 and Top 5 in 2023
Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 16. Global Medical Isotopes Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Medical Isotopes Revenue Market Share 2019 VS 2023 VS 2030
Figure 18. Global Medical Isotopes Revenue Market Share by Type (2019-2030)
Figure 19. Global Medical Isotopes Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Medical Isotopes Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 21. Global Medical Isotopes Revenue Market Share by Application (2019-2030)
Figure 22. North America Medical Isotopes Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Medical Isotopes Revenue by Type (2025-2030) & (US$ Million)
Figure 24. North America Medical Isotopes Revenue Share by Type (2019-2030)
Figure 25. North America Medical Isotopes Revenue by Application (2025-2030) & (US$ Million)
Figure 26. North America Medical Isotopes Revenue Share by Application (2019-2030)
Figure 27. North America Medical Isotopes Revenue Share by Country (2019-2030)
Figure 28. United States Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 29. Canada Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 30. Europe Medical Isotopes Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Medical Isotopes Revenue by Type (2025-2030) & (US$ Million)
Figure 32. Europe Medical Isotopes Revenue Share by Type (2019-2030)
Figure 33. Europe Medical Isotopes Revenue by Application (2025-2030) & (US$ Million)
Figure 34. Europe Medical Isotopes Revenue Share by Application (2019-2030)
Figure 35. Europe Medical Isotopes Revenue Share by Country (2019-2030)
Figure 36. Germany Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. France Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. U.K. Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. Italy Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Russia Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Nordic Countries Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. China Medical Isotopes Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Medical Isotopes Revenue by Type (2025-2030) & (US$ Million)
Figure 44. China Medical Isotopes Revenue Share by Type (2019-2030)
Figure 45. China Medical Isotopes Revenue by Application (2025-2030) & (US$ Million)
Figure 46. China Medical Isotopes Revenue Share by Application (2019-2030)
Figure 47. Asia Medical Isotopes Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 48. Asia Medical Isotopes Revenue by Type (2025-2030) & (US$ Million)
Figure 49. Asia Medical Isotopes Revenue Share by Type (2019-2030)
Figure 50. Asia Medical Isotopes Revenue by Application (2025-2030) & (US$ Million)
Figure 51. Asia Medical Isotopes Revenue Share by Application (2019-2030)
Figure 52. Asia Medical Isotopes Revenue Share by Country (2019-2030)
Figure 53. Japan Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 54. South Korea Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. India Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. Australia Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. China Taiwan Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Southeast Asia Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. MEALA Medical Isotopes Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 60. MEALA Medical Isotopes Revenue by Type (2025-2030) & (US$ Million)
Figure 61. MEALA Medical Isotopes Revenue Share by Type (2019-2030)
Figure 62. MEALA Medical Isotopes Revenue by Application (2025-2030) & (US$ Million)
Figure 63. MEALA Medical Isotopes Revenue Share by Application (2019-2030)
Figure 64. MEALA Medical Isotopes Revenue Share by Country (2019-2030)
Figure 65. Mexico Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. South Korea Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. Brazil Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Israel Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Argentina Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Colombia Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Turkey Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Saudi Arabia Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. UAE Medical Isotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Years Considered
Figure 75. Research Process
Figure 76. Key Executives Interviewed
